These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 16768208)
21. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity. Eyles JE; Butcher WA; Titball RW; Hill J Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of outcomes of combined specific prophylaxis with the antibiotic resistant immunogenic plague pathogen strain and emergency prophylaxis with aminoglycosides in the experimental plague model in white mice]. Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI; Shut'ko AG Antibiot Khimioter; 2003; 48(5):15-9. PubMed ID: 12968464 [TBL] [Abstract][Full Text] [Related]
23. Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection. Welkos S; Norris S; Adamovicz J Clin Vaccine Immunol; 2008 Jul; 15(7):1134-7. PubMed ID: 18480233 [TBL] [Abstract][Full Text] [Related]
24. [Isolation of Yersinia pestis plasmids with transposon markers]. Zarenkov MI; Lebedeva SA Mol Gen Mikrobiol Virusol; 1985 Oct; (10):20-5. PubMed ID: 3025677 [TBL] [Abstract][Full Text] [Related]
25. Immunological characterisation of sub-units of the Yersinia type III secretion apparatus. Hill J; Underwood CD; Sundberg L; Aström H; Leary SE; Forsberg A; Titball RW Adv Exp Med Biol; 2003; 529():415-7. PubMed ID: 12756800 [No Abstract] [Full Text] [Related]
26. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice. Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022 [TBL] [Abstract][Full Text] [Related]
27. [Ultrastructural changes in plague microbes of vaccinal strain EB and alveolar macrophages of guinea pigs during their interaction in vitro]. Pospelova TB; Ternovoĭ VI; Lozovoĭ NV; Golotina NB; Gerasiuk LG Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):58-62. PubMed ID: 7395404 [TBL] [Abstract][Full Text] [Related]
28. [In vitro selection of P. pestis variants with vaccinal properties]. Akimovich VV; Nikoaev II; Zykin LF; Ponomarev NG; Popov AA Zh Mikrobiol Epidemiol Immunobiol; 1965 Jun; 42(6):64-8. PubMed ID: 5870008 [No Abstract] [Full Text] [Related]
29. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680 [TBL] [Abstract][Full Text] [Related]
30. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis). Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228 [TBL] [Abstract][Full Text] [Related]
31. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706 [TBL] [Abstract][Full Text] [Related]
32. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474 [TBL] [Abstract][Full Text] [Related]
34. Kinetics of memory B cell and plasma cell responses in the mice immunized with plague vaccines. Zhang X; Wang Q; Bi Y; Kou Z; Zhou J; Cui Y; Yan Y; Zhou L; Tan Y; Yang H; Du Z; Han Y; Song Y; Zhang P; Zhou D; Yang R; Wang X Scand J Immunol; 2014 Mar; 79(3):157-62. PubMed ID: 24383627 [TBL] [Abstract][Full Text] [Related]
35. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Gupta G; Khan AA; Rao DN Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain]. Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI Antibiot Khimioter; 2004; 49(1):17-21. PubMed ID: 15164519 [TBL] [Abstract][Full Text] [Related]
37. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague. Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090 [TBL] [Abstract][Full Text] [Related]
38. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385 [TBL] [Abstract][Full Text] [Related]
39. [Early protection of animals, immunized by a recombinant plague vaccine, from experimental plague]. Gremiakova TA; Amel'chenko VA; Anisimov GA Biull Eksp Biol Med; 1995 Jan; 119(1):54-7. PubMed ID: 7718805 [No Abstract] [Full Text] [Related]
40. [Translocation of transposons Tn10 and Tn5 in the Yersinia pestis chromosome]. Zarenkov MI; Lebedeva SA; Grebtsova NN Genetika; 1983 Oct; 19(10):1593-603. PubMed ID: 6317517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]